Advertisement
Screener

AYTU BIOPHARMA, INC (AYTU) Debt Conversion, Original Debt, Amount

2.8 / 5 stars · 68/120 Roast Me

AYTU BIOPHARMA, INC Debt Conversion, Original Debt, Amount

AYTU BIOPHARMA, INC (AYTU) reported Debt Conversion, Original Debt, Amount of $221.00 thousand for the 12-month period ending 2017-06-30, per its 10-K filed 2017-08-31.

Discontinued › Cash Flow › Financing Activities

us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2017-08-31

  • AYTU BIOPHARMA, INC debt conversion, original debt, amount for the quarter ending 2017-06-30 was $78.00K, a 0.00% change year-over-year.
  • AYTU BIOPHARMA, INC debt conversion, original debt, amount for the quarter ending 2016-06-30 was $78.00K.
  • AYTU BIOPHARMA, INC debt conversion, original debt, amount for fiscal 2017 was $221.00K, a 0.00% change from fiscal 2016.
  • AYTU BIOPHARMA, INC debt conversion, original debt, amount for fiscal 2016 was $221.00K.
Period endDebt Conversion, Original Debt, Amount 3 monthDebt Conversion, Original Debt, Amount 9 monthDebt Conversion, Original Debt, Amount 12 month
2017-06-30$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31
$221.00K
10-K · filed 2017-08-31
2017-03-31$143.00K
10-Q · filed 2017-05-11
2016-06-30$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31
$221.00K
10-K · filed 2017-08-31
2016-03-31$143.00K
10-Q · filed 2017-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77